Patent directory · USPTO A61K / A61P
Patents matching “Takeda Pharmaceutical Company Limited”
1,022 pharma patents match "Takeda Pharmaceutical Company Limited" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,022 pharmaceutical patents matching "Takeda Pharmaceutical Company Limited" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 8158617
Fused heterocyclic compound and use thereof
granted -
US 8153694
Cyclopropanecarboxylic acid compound
granted -
US 8148367
Renin inhibitors
granted -
US 8143258
Benzothiazole compounds useful for Raf inhibition
granted -
US 8133898
Renin inhibitors
granted -
US 8124606
Substituted 7,8,9,10-tetrahydro-5H-dipyrido[1,2-a:3′,2′-e]pyrazin-6(6aH)-ones
granted -
US 8124617
Imidazopyridine compounds
granted -
US 8119655
Kinase inhibitors
granted -
US 8114620
Diagnostic and therapeutic target PRKX proteins for neurodegenerative diseases
granted -
US 8110585
Bicyclic compound and pharmaceutical use thereof
granted -
US 8105626
Granules containing acid-unstable chemical in large amount
granted -
US 8097737
Process for production of optically active amine derivatives
granted -
US 8092830
Lactic acid polymer and process for producing the same
granted -
US 8093236
Weekly administration of dipeptidyl peptidase inhibitors
granted -
US 8093382
Dipeptidyl peptidase inhibitors
granted -
US 8093403
Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same
granted -
US 8088821
Fused cyclic compounds
granted -
US 8088726
Process for producing sustained-release composition
granted -
US 8084058
Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
granted -
US 8071766
HSP90 inhibitors
granted -
US 8071130
Solid preparation
granted -
US 8067030
Controlled release composition and method of producing the same
granted -
US 8067453
Neurotrophin production/secretion promoting agent
granted -
US 8063066
MAPK/ERK kinase inhibitors
granted